The Technical Analyst
Select Language :
Intellia Therapeutics Inc [NTLA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Intellia Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Intellia Therapeutics Inc is listed at the  Exchange

1.81% $27.51

America/New_York / 28 mar 2024 @ 16:00


Intellia Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2 643.89 mill
EPS: -5.42
P/E: -5.08
Earnings Date: May 01, 2024
SharesOutstanding: 96.11 mill
Avg Daily Volume: 1.584 mill
RATING 2024-03-28
C+
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -5.08 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.86x
Company: PE -5.08 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-4.94
(-117.95%) $-32.45
Date: 2024-03-29
Expected Trading Range (DAY)

$ 25.53 - 29.49

( +/- 7.18%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-01 Sepp-lorenzino Laura Buy 37 966 Common Stock
2024-03-01 Sepp-lorenzino Laura Buy 54 794 Stock Option (right to buy)
2024-03-01 Basta James Buy 32 394 Common Stock
2024-03-04 Basta James Sell 2 297 Common Stock
2024-03-01 Basta James Buy 46 752 Stock Option (right to buy)
INSIDER POWER
85.54
Last 100 transactions
Buy: 1 569 411 | Sell: 123 854

Forecast: 16:00 - $27.47

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $27.47
Forecast 2: 16:00 - $27.47
Forecast 3: 16:00 - $27.47
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $27.51 (1.81% )
Volume 1.043 mill
Avg. Vol. 1.584 mill
% of Avg. Vol 65.82 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Intellia Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Intellia Therapeutics Inc

RSI

Intraday RSI14 chart for Intellia Therapeutics Inc

Last 10 Buy & Sell Signals For NTLA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:36sell$27.60N/AActive
Profile picture for
            Intellia Therapeutics Inc

NTLA

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for the treatment of sickle cell disease; Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; Ospedale San Raffaele; and a strategic collaboration with SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases. The company was formerly known as AZRN, Inc. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
TIAUSDMar 29 - 08:3815.02
ETHUPUSDMar 29 - 08:3834.55
MPLUSDMar 29 - 08:3422.12
DCRUSDMar 29 - 08:30$28.20
RBNUSDMar 29 - 08:301.670
GTUSDMar 29 - 08:30$9.91
BORAUSDMar 29 - 08:29$0.227
ATORUSDMar 29 - 08:293.34
IONUSDMar 29 - 08:24451.18
RADUSDMar 29 - 08:24$3.39

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.